Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

6. TRASTORNOS CONCURRENTESHall RG y colab. (1995) Level of functioning, severity of illness, and smokingstatus among chronic psychiatric patients. Journal of Nervous and MentalDisorders, 183:468–471.Hambrecht M, Hafner H (1996) Substance abuse and the onset of schizophrenia.Biological Psychiatry, 40:1155–1163.Harris GC, Aston-Jones G (1994) Involvement of D2 dopamine receptors in thenucleus accumbens in the opiate withdrawal syndrome. Nature, 371:155–157.Harrison AA, Liem YT, Markou A (2001) Fluoxetine combined with a serotonin-1Areceptor antagonist reversed reward deficits observed during nicotineand amphetamine withdrawal in rats. Neuropsychopharmacology, 25:55–71.Harvey PD, Keefe RS (2001) Studies of cognitive change in patients with schizophreniafollowing novel antipsychotic treatment. American Journal of Psychiatry,158:176–184.Hazlett EA y colab. (2000) Hypofrontality in unmedicated schizophreniapatients studied with PET during performance of a serial verbal learning task.Schizophrenia Research, 43:33–46.Heckers S (2001) Neuroimaging studies of the hippocampus in schizophrenia.Hippocampus, 11:520–528.Heilig M, Widerlov E (1990) Neuropeptide Y: an overview of central distribution,functional aspects, and possible involvement in neuropsychiatric illnesses.Acta Psychiatrica Scandinavica, 82:95–114.Heilig M y colab. (1994) Corticotropin-releasing factor and neuropeptide Y: rolein emotional integration. Trends in Neuroscience, 17:80–85.Hendrie CA, Sairally J, Starkey N (1998) Self-medication with alcohol appearsnot to be an effective treatment for the control of depression. Journal ofPsychopharmacology, 12:108.Heninger GR, Delgado PL, Charney DS (1996) The revised monoamine theoryof depression: a modulatory role for monoamines, based on new findingsfrom monoamine depletion experiments in humans. Pharmacopsychiatry,29:2–11.Henningfield JE, Johnson RE, Jasinski DR (1987) Clinical procedures for theassessment of abuse potential. En: Bozarth MA, ed. Methods of assessing the reinforcingproperties of abused drugs. Nueva York, NY, EE.UU. Springer-Verlag:573–590.Himmelsbach CK (1943) Can the euphoric, analgetic, and physical dependenceeffects of drugs be separated? IV. With reference to physical dependence.Federation Proceedings, 2:201–203.Hitsman B y colab. (1999) Antidepressant pharmacotherapy helps some cigarettesmokers more than others. Journal of Consulting and Clinical Psychology,67:547–554.Holden C (2001) Drug addiction: zapping memory center triggers drug craving.Science, 292:1039.Hughes JR (1992) Tobacco withdrawal in self-quitters. Journal of Consulting andClinical Psychology, 60:689–697.197
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASHughes JR (1996) The future of smoking cessation therapy in the United States.Addiction, 91:1797–1802.Hughes JR, Hatsukami D (1992) The nicotine withdrawal syndrome: a briefreview and update. International Journal on Smoking Cessation, 1:21–26.Hughes JR, Higgins ST, Bickel WK (1994) Nicotine withdrawal versus otherdrug withdrawal syndromes: similarities and dissimilarities. Addiction,89:1461–1470.Hughes JR y colab. (1984) Effect of nicotine on the tobacco withdrawal syndrome.Psychopharmacology, 83:82–87.Hughes JR y colab. (1986) Prevalence of smoking among psychiatric outpatients.American Journal of Psychiatry, 143:993–997.Hughes JR y colab. (1991) Symptoms of tobacco withdrawal: a replication andextension. Archives of General Psychiatry, 48:52–59.Hurt RD y colab. (1997) A comparison of sustained-release buproprion andplacebo for smoking cessation. New England Journal of Medicine,337:1195–1202.Imperato A y colab. (1992) Chronic cocaine alters extracellular dopamine: neurochemicalbasis for addiction. European Journal of Pharmacology, 212:299–300.Jaffe JH (1990) Drug addiction and drug abuse. En: Goodman AG y colab., eds.Goodman and Gilman’s pharmacological basis of therapeutics, 8a edición. NuevaYork, NY, EE.UU. Pergamon Press:522–573.Jarvik ME (1991) Beneficial effects of nicotine. British Journal of Addiction,86:571–575.Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model ofschizophrenia. American Journal of Psychiatry, 148:1301–1308.Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine:from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.Neuropsychopharmacology, 20:201–225.Jibson MD, Tandon R (1998) New atypical antipsychotic medications. Journalof Psychiatric Research, 32:215–228.Jorenby DE y colab. (1999) A controlled trial of sustained-release buproprion, anicotine patch, or both for smoking cessation. New England Journal of Medicine,340:685–691.Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptorstimulation in the ventral tegmental area and amygdala in behavioral sensitizationto cocaine. Journal of Pharmacology and Experimental Therapeutics,267:486–495.Kalivas PW, Duffy P (1998) Repeated cocaine administration alters extracellularglutamate in the ventral tegmental area. Journal of Neurochemistry,70:1497–1502.Kalivas PW, Duffy P, Barrow J (1989) Regulation of the mesocorticolimbicdopamine system by glutamic acid receptor subtypes. Journal of Pharmacologyand Experimental Therapeutics, 251:378–387.198
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 88 and 89:
Capítulo 4Psicofarmacología de la
Page 90 and 91:
4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Capítulo 5Bases Genéticas de lasF
Page 148 and 149:
5. BASES GENÉTICAS DE LAS FARMACOD
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 190 and 191: Capítulo 6Trastornos ConcurrentesI
Page 192 and 193: 6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195: 6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197: 6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199: 6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201: 6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203: 6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205: 6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207: 6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209: 6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211: 6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213: 6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215: 6. TRASTORNOS CONCURRENTESCarol G y
Page 216 and 217: 6. TRASTORNOS CONCURRENTESdepressio
Page 220 and 221: 6. TRASTORNOS CONCURRENTESKapur S,
Page 222 and 223: 6. TRASTORNOS CONCURRENTESMansvelde
Page 224 and 225: 6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227: 6. TRASTORNOS CONCURRENTESSevy S y
Page 228: 6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 269 and 270:
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?